Skip to main content
Ingredients/Compound/19-Nor-DHEA

19-Nor-DHEA.

Strength pending.The research strength is not set yet.

It's a synthetic steroid precursor built so conversion runs toward 19-nortestosterone rather than testosterone. It's sold for muscle and strength, and it acts as a hormone, not a nutrient.

NDCompound
19-Nor-DHEAIngredientMD
Category
Compound

What 19-Nor-DHEA is, and what it does.

Does it work
Anyone tested in sport or at work needs one fact first: this class leaves urinary metabolites that doping control looks for by name. That decides the question before anything else does.
How much to take
No dose figure is on record. Conversion runs through two rate-limited enzyme steps, so an oral amount doesn't map onto a predictable hormone level in the body.
Time to feel it
Changes with this class are described across weeks of use, and blood markers move earlier than anything a person notices.
The first dose
Day one is usually uneventful. The first measurable changes land on a lipid panel and on liver enzyme markers rather than in how you feel.
With regular use
Weeks of use lower LH and FSH output and with it your own testosterone production, and this class shifts HDL cholesterol and liver enzyme markers.
How well tolerated
Hard on lipid and liver markers, and suppression of your own hormone output is expected rather than unusual. Not for anyone pregnant, under 18, or using it without clinician monitoring.
How it feels
People on this class report more drive and aggression, oilier skin and broken sleep. Those are hormonal effects rather than a signal that things are going well.
The overlooked benefit
One missing methyl group is the whole story. Removing C19 is what routes it toward nandrolone chemistry, and it's also what makes its urinary metabolite so recognisable in a test.

The proof, claim by claim.

These words describe the research, not the molecule's worth. Research strength is how much work stands behind one claim, and it is never a product score.

  • conversion toward 19-nortestosterone after ingestionNarrative review
  • urinary 19-norandrosterone detectable after useNarrative review
  • lower HDL cholesterol with oral androgen precursorsRandomised trial
  • suppression of luteinising hormone during useNarrative review
PubMedCochraneClinicalTrials.govNIH ODSSUPP.AILabs test. IngredientMD verifies.PubMedCochraneClinicalTrials.govNIH ODSSUPP.AILabs test. IngredientMD verifies.
Pairs well with7 on file

Why these belong in the same formula. Each row says what the basis is, from settled biochemistry through to a trial that measured the pair.

19-Nor-DHEA + Diindolylmethane (DIM)Established phase I oestrogen metabolism chemistry

A 19-nor prohormone is designed to convert downstream toward 19-nortestosterone, but a share of any androgen pool is also aromatised to oestrogens. DIM shifts oestradiol metabolism toward 2-hydroxy metabolites by inducing CYP1A1. That is why the pair shows up together, and it is a metabolism argument rather than a demonstrated outcome.

19-Nor-DHEA + Calcium D-GlucarateBeta-glucuronidase inhibition and steroid conjugate excretion

Steroid hormones and their metabolites are cleared as glucuronide conjugates. Calcium D-glucarate inhibits gut beta-glucuronidase, so fewer conjugates are deconjugated and reabsorbed. The mechanism is real. Whether it meaningfully changes circulating steroid levels at supplement doses has not been established.

19-Nor-DHEA + ZincZinc is a required cofactor across steroidogenic and androgen-handling enzymes

Zinc is structurally required by the androgen receptor's DNA-binding domain and by multiple steroid-metabolising enzymes. In frank deficiency, androgen signalling is impaired regardless of substrate supply. Correcting a deficiency is not the same as adding zinc on top of adequate status, and only the first has support.

19-Nor-DHEA + Milk Thistle (Silymarin)Standard co-formulation with oral steroid precursors on hepatic grounds

Oral prohormones pass through the liver at high concentration and are associated with shifts in lipid panels and liver enzymes. Silymarin is routinely stacked on that basis. The pairing is convention among users, not something that has been tested as a protective strategy for this compound.

19-Nor-DHEA + BoronReported effects on sex hormone-binding globulin

Small human studies report that boron intake shifts sex hormone-binding globulin, which changes the free fraction of circulating androgens rather than the total. A change in a binding protein is a marker shift, not an outcome. The interaction with a 19-nor precursor specifically has never been examined.

19-Nor-DHEA + AshwagandhaOverlapping action on the hypothalamic-pituitary axis

Exogenous androgen precursors suppress endogenous gonadotropin output through negative feedback, and ashwagandha is used with an eye to the same axis from the other direction. Combining them means two inputs to one feedback loop, so the net effect is not predictable from either alone. Worth flagging rather than assuming additive.

19-Nor-DHEA + Vitamin D3Correlational literature linking vitamin D status and androgen levels

Observational data links low vitamin D status with lower circulating testosterone in men, and intervention results are mixed. An association is not a cause, and no study has combined vitamin D with a 19-nor prohormone. Read this as background rather than a stack recommendation.

Who should be cautious

Nothing specific on file for 19-Nor-DHEA. Match the label to the daily amount above, and tell your doctor what you take.

Not medical advice. Show the label to your pharmacist.

What 19-Nor-DHEA actually does.

Established

It is one carbon different from the more familiar DHEA skeleton, and that one carbon is what sends it down a different path in the body.

Established

Turning this precursor into its active hormone form takes two separate enzyme steps, and both steps are limited and vary by tissue, so a given oral dose doesn't translate to a predictable level of active hormone.

Established

Any outside androgen precursor like this one triggers the body's feedback loop, lowering the brain's hormone signals and, with them, the body's own hormone production. That suppression is a direct result of the feedback loop, not a random side effect.

Established

Breakdown products of this compound show up in urine and are standard targets in doping control. Anyone facing sport or workplace drug testing should expect a positive result from this ingredient class.

Made in a lab, 5 steps on record

Where 19-Nor-DHEA comes from.

It starts from a plant sterol but it is built in a chemical plant. Nothing about it is plant-derived in the sense people usually mean, and the key structural change is made in a reactor.

Chemically synthesised. The molecule is identical to the one a plant or an animal makes, and building it deliberately means a known purity, a fixed dose and no crop contaminants. For several nutrients this is the only route that reaches a usable amount.

Starts as
Plant sterol

Diosgenin from Dioscorea species or soy phytosterols are the usual starting sterols for industrial steroid synthesis.

Converted by
Microbial side-chain cleavage

Mycobacterium strains degrade the sterol side chain to give androstenedione-type intermediates in a fermentation step.

Converted by
Chemical demethylation to the 19-nor skeleton

Removal of the C19 angular methyl group, the step that defines the 19-nor class, is done chemically. This is not something a plant produces.

Purified by
Crystallisation

Recrystallised to pharmaceutical-grade purity and assayed by HPLC.

Ends up as
Free base or ester

Delivered as the free steroid or esterified for lipid delivery, then capsuled or dispersed in an oil base.

The forms it comes in.

Cyclodextrin-complexed 19-nor-DHEAHost-guest inclusion complex that improves aqueous dispersion of a poorly soluble steroidFits Sublingual and fast-dispersing formatsTrade-off Complexation raises cost and dilutes the steroid content per gram of powderFormulation aid
What the strongest studies found

The essence, in one line each.

  1. Endogenous sex steroid hormone and SHBG levels were associated with all-cause and cause-specific mortality across the cohorts examined.Cohort study. Raeisi-Dehkordi H et al., 2025 (The Journal of Clinical Endocrinology and Metabolism). PMID 40333346
  2. A pilot study compared serum DHEA levels between groups and reported a difference, in an exploratory design with a small sample.Case-control. Nenezic N et al., 2025 (Cureus). PMID 41235013

These are the studies our verdict leans on, chosen from the 2 we read for 19-Nor-DHEA. The full linked list is below.

FDA Disclaimer: These statements have not been evaluated by the Food and Drug Administration. This information is for educational purposes only and is not intended to diagnose, treat, cure, or prevent any disease. Consult your healthcare provider before starting any supplement regimen.